Fuad El-Hibri
2018
In 2018, Fuad El-Hibri earned a total compensation of $3M as Executive Chairman of the Board of Directors at Emergent BioSolutions, a 16% increase compared to previous year.
Compensation breakdown
| Option Awards | $957,481 |
|---|---|
| Salary | $1,047,031 |
| Stock Awards | $957,456 |
| Other | $8,250 |
| Total | $2,970,218 |
El-Hibri received $1M in salary, accounting for 35% of the total pay in 2018.
El-Hibri also received $957.5K in option awards, $957.5K in stock awards and $8.3K in other compensation.
Rankings
In 2018, Fuad El-Hibri's compensation ranked 3,907th out of 14,244 executives tracked by ExecPay. In other words, El-Hibri earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,907 out of 14,244 | 73rd |
Division Manufacturing | 1,442 out of 5,765 | 75th |
Major group Chemicals And Allied Products | 512 out of 2,128 | 76th |
Industry group Drugs | 429 out of 1,817 | 76th |
Industry Pharmaceutical Preparations | 333 out of 1,391 | 76th |
Source: SEC filing on April 9, 2020.
El-Hibri's colleagues
We found six more compensation records of executives who worked with Fuad El-Hibri at Emergent BioSolutions in 2018.
2018
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
2018
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2018
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2018
Atul Saran
Emergent BioSolutions
General Counsel
2018
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
2018
Richard Lindahl
Emergent BioSolutions